Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 851-875 of 946 matching filings.

Per page
25
Current page
35
8-K File 001-36297

8-K

Filing date
12 Nov 2014
Reporting date
12 Nov 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
04 Nov 2014
Reporting date
30 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Oct 2014
Reporting date
28 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 Oct 2014
Reporting date
17 Oct 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2014
Reporting date
17 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2014
Reporting date
17 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
19 Sep 2014
Reporting date
17 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
02 Sep 2014
Reporting date
02 Sep 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-198499

S-8

Filing date
29 Aug 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
29 Aug 2014
Reporting date
26 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
20 Aug 2014
Reporting date
18 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

FORM 8-K

Filing date
12 Aug 2014
Reporting date
12 Aug 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
424B4 File 333-196582

424B4

Filing date
19 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-196582

EFFECT filing

Filing date
18 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-196582

FWP

Filing date
18 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-196582

AMENDMENT NO.2 TO FORM S-1

Filing date
18 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-196582

AMENDMENT NO.1 TO FORM S-1

Filing date
16 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-196582

FORM S-1

Filing date
06 Jun 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 May 2014
Reporting date
19 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 May 2014
Reporting date
19 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 May 2014
Reporting date
19 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
21 May 2014
Reporting date
19 May 2014
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .